Interestingly, both BC and MET treatments induced the expression in muscle of genes for proteins in the insulin signaling pathway (Insr and Irs1), yet without additive effects in the combined BC+MET treatment group: on the contrary, Irs1 expression was less induced in the BC+MET group than in the BC and MET groups. The gene discussed is IRS1; the disease is breast cancer.